| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0312832.9AGB0312832D0 (en) | 2003-06-04 | 2003-06-04 | 2-amino-pyridine derivatives useful for the treatment of diseases |
| CA002527788ACA2527788A1 (en) | 2003-06-04 | 2004-06-01 | 2-(6-amino-pyridin-3-yl)-2-hydroxyethylamine derivatives as beta 2-adrenoceptors agonists |
| JP2006508431AJP2006526613A (en) | 2003-06-04 | 2004-06-01 | 2- (6-Amino-pyridin-3-yl) -2-hydroxyethylamine derivatives as β2-adrenergic receptor agonists |
| PE2004000553APE20050628A1 (en) | 2003-06-04 | 2004-06-01 | 2-AMINO-PYRIDINE DERIVATIVES AS ß-2 AGONISTS |
| ES04735621TES2291882T3 (en) | 2003-06-04 | 2004-06-01 | DERIVATIVES OF 2- (6-AMINO-PIRIDIN-3-IL) -2-HYDROXYETHYLAMINE AS BETA 2 ADRENOCEPTORS AGONISTS. |
| MXPA05012840AMXPA05012840A (en) | 2003-06-04 | 2004-06-01 | 2-(6-amino-pyridin-3-yl)-2-hydroxyethylamine derivatives as beta 2-adrenoceptors agonists. |
| EP04735621AEP1633715B1 (en) | 2003-06-04 | 2004-06-01 | 2-(6-amino-pyridin-3-yl)-2-hydroxyethylamine derivatives as beta 2-adrenoceptors agonists |
| PCT/IB2004/001850WO2004108676A1 (en) | 2003-06-04 | 2004-06-01 | 2-(6-amino-pyridin-3-yl)-2-hydroxyethylamine derivatives as beta 2-adrenoceptors agonists |
| AT04735621TATE372321T1 (en) | 2003-06-04 | 2004-06-01 | 2-(6-AMINO-PYRIDINE-3-YL)-2-HYDROXYETHYLAMINE COMPOUNDS AS BETA 2-ADRENOCEPTOR AGONISTS |
| DE602004008773TDE602004008773T2 (en) | 2003-06-04 | 2004-06-01 | 2- (6-AMINO-PYRIDIN-3-YL) -2-HYDROXYETHYLAMINE COMPOUNDS AS BETA 2-ADRENOCEPTORS AGONISTS |
| BRPI0410946-5ABRPI0410946A (en) | 2003-06-04 | 2004-06-01 | 2- (6-amino-pyridin-3-yl) -2-hydroxyethylamine derivatives as beta 2 adrenergic receptor agonists |
| UY28339AUY28339A1 (en) | 2003-06-04 | 2004-06-02 | USED 2-AMINO-PYRIDINE DERIVATIVES FOR THE TREATMENT OF DISEASES |
| CL200401366ACL2004001366A1 (en) | 2003-06-04 | 2004-06-03 | COMPOUNDS DERIVED FROM 2- (6-AMINO-PIRIDIN-2-IL) -2-SUBSTITUTED HYDROXYETHYLAMINE, B2-ADRENOCEPTORS AGONISTS; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; PHARMACEUTICAL COMPOSITION AND USE OF THE COMPOUND IN THE TREATMENT OF ASTHMA, BRONCHITIS C |
| PA20048604301APA8604301A1 (en) | 2003-06-04 | 2004-06-03 | USED 2-AMINO-PYRIDINE DERIVATIVES FOR THE TREATMENT OF DISEASES |
| NL1026329ANL1026329C2 (en) | 2003-06-04 | 2004-06-03 | 2-Amino-pyridine derivatives useful for the treatment of diseases. |
| ARP040101904AAR044475A1 (en) | 2003-06-04 | 2004-06-03 | DERIVATIVES OF 2-AMINO-PYRIDINE USEFUL FOR THE TREATMENT OF DISEASES |
| TW093115990ATW200524603A (en) | 2003-06-04 | 2004-06-03 | 2-amino-pyridine derivatives useful for the treatment of diseases |
| GT200400116AGT200400116A (en) | 2003-06-04 | 2004-06-03 | USED 2-AMINO-PYRIDINE DERIVATIVES FOR THE TREATMENT OF DISEASES. |
| US10/860,772US7375100B2 (en) | 2003-06-04 | 2004-06-03 | 2-amino-pyridine derivatives useful for the treatment of diseases |
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0312832.9AGB0312832D0 (en) | 2003-06-04 | 2003-06-04 | 2-amino-pyridine derivatives useful for the treatment of diseases |
| Publication Number | Publication Date |
|---|---|
| GB0312832D0true GB0312832D0 (en) | 2003-07-09 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB0312832.9ACeasedGB0312832D0 (en) | 2003-06-04 | 2003-06-04 | 2-amino-pyridine derivatives useful for the treatment of diseases |
| Country | Link |
|---|---|
| EP (1) | EP1633715B1 (en) |
| JP (1) | JP2006526613A (en) |
| AR (1) | AR044475A1 (en) |
| AT (1) | ATE372321T1 (en) |
| BR (1) | BRPI0410946A (en) |
| CA (1) | CA2527788A1 (en) |
| CL (1) | CL2004001366A1 (en) |
| DE (1) | DE602004008773T2 (en) |
| ES (1) | ES2291882T3 (en) |
| GB (1) | GB0312832D0 (en) |
| GT (1) | GT200400116A (en) |
| MX (1) | MXPA05012840A (en) |
| NL (1) | NL1026329C2 (en) |
| PA (1) | PA8604301A1 (en) |
| PE (1) | PE20050628A1 (en) |
| TW (1) | TW200524603A (en) |
| UY (1) | UY28339A1 (en) |
| WO (1) | WO2004108676A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0411056D0 (en) | 2004-05-18 | 2004-06-23 | Novartis Ag | Organic compounds |
| AR049384A1 (en) | 2004-05-24 | 2006-07-26 | Glaxo Group Ltd | PURINA DERIVATIVES |
| UA87854C2 (en) | 2004-06-07 | 2009-08-25 | Мерк Энд Ко., Инк. | N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators |
| AU2005286728A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase |
| CA2580857A1 (en) | 2004-09-20 | 2006-09-28 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| AU2005286648A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors |
| WO2006034315A2 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes |
| WO2006034440A2 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| CA2580762A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as therapeutic agents |
| AU2005286731A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturase |
| GT200500281A (en) | 2004-10-22 | 2006-04-24 | Novartis Ag | ORGANIC COMPOUNDS. |
| GB0424284D0 (en) | 2004-11-02 | 2004-12-01 | Novartis Ag | Organic compounds |
| GB0426164D0 (en) | 2004-11-29 | 2004-12-29 | Novartis Ag | Organic compounds |
| WO2007130075A1 (en) | 2005-06-03 | 2007-11-15 | Xenon Pharmaceuticals Inc. | Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors |
| GB0514809D0 (en) | 2005-07-19 | 2005-08-24 | Glaxo Group Ltd | Compounds |
| GB0516313D0 (en) | 2005-08-08 | 2005-09-14 | Argenta Discovery Ltd | Azole derivatives and their uses |
| EP2281813A1 (en) | 2005-08-08 | 2011-02-09 | Pulmagen Therapeutics (Synergy) Limited | Bicyclo[2.2.1]hept-7-ylamine derivatives and their uses |
| MY144906A (en) | 2005-10-21 | 2011-11-30 | Novartis Ag | Human antibodies against il13 and therapeutic uses |
| GB0601951D0 (en) | 2006-01-31 | 2006-03-15 | Novartis Ag | Organic compounds |
| JP5373599B2 (en) | 2006-04-21 | 2013-12-18 | ノバルティス アーゲー | Purine derivatives for use as adenosine A2A receptor agonists |
| ES2392999T3 (en)* | 2006-06-09 | 2012-12-17 | Parion Sciences, Inc. | Phenyl-substituted pyrazinoylguanidine sodium channel blockers that have beta agonist activity |
| JP5483880B2 (en) | 2006-10-23 | 2014-05-07 | 武田薬品工業株式会社 | Iminopyridine derivatives and uses thereof |
| CN101687851B (en) | 2007-05-07 | 2013-02-27 | 诺瓦提斯公司 | Organic compounds |
| EA017919B1 (en) | 2007-12-10 | 2013-04-30 | Новартис Аг | Pyrazine-2 carboxamide derivatives for treating diseases which respond to the blocade of the epithelial sodium channels |
| PT2231642E (en) | 2008-01-11 | 2014-03-12 | Novartis Ag | Pyrimidines as kinase inhibitors |
| US8481569B2 (en) | 2008-04-23 | 2013-07-09 | Takeda Pharmaceutical Company Limited | Iminopyridine derivatives and use thereof |
| EA201001848A1 (en) | 2008-06-10 | 2011-08-30 | Новартис Аг | DERIVATIVES OF PIRAZINE AS EPITELIAL SODIUM CHANNEL BLOCKS |
| US8236786B2 (en) | 2008-08-07 | 2012-08-07 | Pulmagen Therapeutics (Inflammation) Limited | Respiratory disease treatment |
| DE102008049675A1 (en) | 2008-09-30 | 2010-04-01 | Markus Dr. Heinrich | Process for the preparation of 3-aminobiphenyls |
| WO2010076553A1 (en) | 2008-12-30 | 2010-07-08 | Dr. Reddy's Laboratories Ltd | Sulfonamide compounds for the treatment of respiratory disorders |
| WO2010150014A1 (en) | 2009-06-24 | 2010-12-29 | Pulmagen Therapeutics (Inflammation) Limited | 5r- 5 -deuterated glitazones for respiratory disease treatment |
| JP2013508414A (en) | 2009-10-22 | 2013-03-07 | バーテックス ファーマシューティカルズ インコーポレイテッド | Compositions for the treatment of cystic fibrosis and other chronic diseases |
| GB0918924D0 (en) | 2009-10-28 | 2009-12-16 | Vantia Ltd | Azaindole derivatives |
| GB0918923D0 (en) | 2009-10-28 | 2009-12-16 | Vantia Ltd | Aminothiazole derivatives |
| GB0918922D0 (en) | 2009-10-28 | 2009-12-16 | Vantia Ltd | Aminopyridine derivatives |
| WO2011098746A1 (en) | 2010-02-09 | 2011-08-18 | Pulmagen Therapeutics (Inflammation) Limited | Crystalline acid addition salts of ( 5r) -enanti0mer of pioglitazone |
| GB201002224D0 (en) | 2010-02-10 | 2010-03-31 | Argenta Therapeutics Ltd | Respiratory disease treatment |
| GB201002243D0 (en) | 2010-02-10 | 2010-03-31 | Argenta Therapeutics Ltd | Respiratory disease treatment |
| US8247436B2 (en) | 2010-03-19 | 2012-08-21 | Novartis Ag | Pyridine and pyrazine derivative for the treatment of CF |
| UY33597A (en) | 2010-09-09 | 2012-04-30 | Irm Llc | COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF THE TRK |
| WO2012034095A1 (en) | 2010-09-09 | 2012-03-15 | Irm Llc | Compounds and compositions as trk inhibitors |
| US8372845B2 (en) | 2010-09-17 | 2013-02-12 | Novartis Ag | Pyrazine derivatives as enac blockers |
| KR20140014184A (en) | 2011-02-25 | 2014-02-05 | 아이알엠 엘엘씨 | Compounds and compositions as trk inhibitors |
| UY34305A (en) | 2011-09-01 | 2013-04-30 | Novartis Ag | DERIVATIVES OF BICYCLIC HETEROCICLES FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION |
| ES2882807T3 (en) | 2011-09-16 | 2021-12-02 | Novartis Ag | N-substituted heterocyclyl carboxamides |
| WO2013038381A1 (en) | 2011-09-16 | 2013-03-21 | Novartis Ag | Pyridine/pyrazine amide derivatives |
| WO2013038373A1 (en) | 2011-09-16 | 2013-03-21 | Novartis Ag | Pyridine amide derivatives |
| WO2013038378A1 (en) | 2011-09-16 | 2013-03-21 | Novartis Ag | Pyridine amide derivatives |
| ES2558457T3 (en) | 2011-09-16 | 2016-02-04 | Novartis Ag | Heterocyclic compounds for the treatment of cystic fibrosis |
| US8809340B2 (en) | 2012-03-19 | 2014-08-19 | Novartis Ag | Crystalline form |
| US9073921B2 (en) | 2013-03-01 | 2015-07-07 | Novartis Ag | Salt forms of bicyclic heterocyclic derivatives |
| EA032075B1 (en) | 2014-04-24 | 2019-04-30 | Новартис Аг | Amino pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors |
| KR20160141856A (en) | 2014-04-24 | 2016-12-09 | 노파르티스 아게 | Pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors |
| CN106458980A (en) | 2014-04-24 | 2017-02-22 | 诺华股份有限公司 | Amino pyridine derivatives as phosphatidylinositol 3-kinase inhibitors |
| WO2020250116A1 (en) | 2019-06-10 | 2020-12-17 | Novartis Ag | Pyridine and pyrazine derivative for the treatment of cf, copd, and bronchiectasis |
| JOP20220044A1 (en) | 2019-08-28 | 2023-01-30 | Novartis Ag | Hetero-substituted 1,3-phenylaryl derivatives and their use in the treatment of disease |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4358455A (en)* | 1980-12-23 | 1982-11-09 | Merck & Co., Inc. | Aralkylamindethanol heterocyclic compounds |
| CA2220399A1 (en)* | 1995-05-10 | 1996-11-14 | Pfizer Inc. | .beta.-adrenergic agonists |
| DE60015036T2 (en)* | 1999-07-23 | 2006-03-02 | Pfizer Products Inc., Groton | Intermediates and a method of producing beta3-adrenergic receptor agonist |
| TWI249515B (en)* | 2001-11-13 | 2006-02-21 | Theravance Inc | Aryl aniline beta2 adrenergic receptor agonists |
| GB0217225D0 (en)* | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicinal compounds |
| AP2005003283A0 (en)* | 2002-10-11 | 2005-06-30 | Pfizer | Indole derivatives useful for the treatment os diseases |
| Publication number | Publication date |
|---|---|
| JP2006526613A (en) | 2006-11-24 |
| EP1633715A1 (en) | 2006-03-15 |
| PE20050628A1 (en) | 2005-08-30 |
| ES2291882T3 (en) | 2008-03-01 |
| BRPI0410946A (en) | 2006-06-27 |
| DE602004008773D1 (en) | 2007-10-18 |
| EP1633715B1 (en) | 2007-09-05 |
| AR044475A1 (en) | 2005-09-14 |
| NL1026329C2 (en) | 2005-07-26 |
| TW200524603A (en) | 2005-08-01 |
| CL2004001366A1 (en) | 2005-05-06 |
| CA2527788A1 (en) | 2004-12-16 |
| UY28339A1 (en) | 2005-01-31 |
| MXPA05012840A (en) | 2006-02-13 |
| DE602004008773T2 (en) | 2008-01-10 |
| GT200400116A (en) | 2005-03-03 |
| NL1026329A1 (en) | 2004-12-07 |
| PA8604301A1 (en) | 2004-12-16 |
| WO2004108676A1 (en) | 2004-12-16 |
| ATE372321T1 (en) | 2007-09-15 |
| Publication | Publication Date | Title |
|---|---|---|
| GB0312832D0 (en) | 2-amino-pyridine derivatives useful for the treatment of diseases | |
| HK1095320A1 (en) | Pyrimidine derivatives useful for the treatment of diseases mediated by crth2 | |
| HUS1500034I1 (en) | Indolidone derivatives for the treatment or prevention of fibrotic diseases | |
| AP2005003283A0 (en) | Indole derivatives useful for the treatment os diseases | |
| HK1096083A1 (en) | Sulfonamide derivatives for the treatment of diseases | |
| HK1087103A1 (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
| NL1026327A1 (en) | 2-Amino-pyridine derivatives useful for the treatment of diseases. | |
| NO20052894D0 (en) | 4-tetrazolyl-4-phenylpiperidine derivatives for the treatment of pain | |
| IL176472A0 (en) | Process for the preparation of pyridine derivatives | |
| AP2006003669A0 (en) | Sulfonamide derivatives for the treatment of diseases | |
| GB0329874D0 (en) | Compounds useful for the treatment of diseases | |
| PL1685125T3 (en) | Pyrrole derivatives useful for the treatment of proliferative diseases | |
| PT1487828E (en) | Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases | |
| EP1611120A4 (en) | Novel methods for the treatment of inflammatory diseases | |
| IL165137A0 (en) | Process for the preparation of thioalkylamine derivatives | |
| GB0201025D0 (en) | The treatment of degenerative diseases | |
| GB0312840D0 (en) | 2-amino-pyridine derivatives useful for the treatment of diseases | |
| GB0312842D0 (en) | 2-amino-pyridine derivatives useful for the treatment of diseases | |
| GB0217205D0 (en) | 2-Amino-pyridine derivatives useful for the treatment of diseases | |
| AU2003232844A1 (en) | Morpholin-acetamide derivatives for the treatment of inflammatory diseases | |
| IL175611A0 (en) | Combinations for the treatment of proliferative diseases | |
| GB0425054D0 (en) | Formamide derivatives for the treatment of diseases | |
| SI1663244T1 (en) | Pteridine derivatives for the treatment of tnf-alpha-related diseases. | |
| GB0408297D0 (en) | Indole derivatives for the treatment of diseases | |
| GB0425064D0 (en) | Compounds useful for the treatment of diseases |
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |